OL-022 Diagnostic efficacy of monoclonal antibody based sandwich ELISA for detection of Fasciola gigantica excretory/secretory antigens in both serum and stool A. El-Bassiouny 1 , T. Diab 2 *, I. Aly 2 , S. Mohamed 1 , M. Zoheiry 1 , W. Mansour 1 , W. Safwat 3 , Z. Demerdash 1 . 1 Theodor Bilharz Research Institute, Immunology Dep., 2 Theodor Bilharz Research Institute, Parasitology Dep., 3 Theodor Bilharz Research Institute, Gastroenterology and Hepatology Dep, Egypt This research was carried out to develop a reliable monoclonal antibody (MoAb)-based sandwich ELISA for the diagnosis of active Fasciola gigantica infection in both serum and stool for comparative purposes. From a panel of MoAbs raised against F. gigantica excretory/secretory antigens (ES Ags), a pair (12B/11D/3F and 10A/9D/10G) was chosen due to its high reactivity and strict specificity to Fasciola antigen by indirect ELISA. The 2 MoAbs were of the IgG 1 and IgG 2a subclasses, respectively. Using SDS-PAGE and EITB, the selected MoAbs recognized 83, 64, 45 and 26 kDa bands of ES Ags. The lower detection limit of ELISA assay was 3 ng/ml. In stool, the sensitivity, specificity and diagnostic efficacy of ELISA was 96%, 98.2 and 97.1% while in serum they were 94%, 94.6% and 94.3%, respectively. Moreover, a positive correlation was found between ova count in stool of Fasciola infected patients and the OD readings of ELISA in both stool and serum samples (r = 0.730, p < 0.01 and r = 0.608; p < 0.01, respectively). These data showed that the use of MoAb-based sandwich ELISA for the detection of Fasciola coproantigens in stool specimens was more superior than in serum samples; it provides a highly efficient, non-invasive technique for the diagnosis of active Fasciola infection. Background: Leishmaniasis is one of the six most common parasitic infections in tropical regions. There are different therapeutic modalities. However therapeutic resistance is developed and resulted in numerous problems. So evaluation of other therapeutic modalities is performed extensively. We compared the therapeutic response of cutaneous leishmaniasis with Glucantime and Peganum harmala extracts (aqueous and ethanol) in animal model. Methods: This experimental study was conducted in Shahed University during 2008 2009. The therapeutic response of cutaneous leishmaniasis to Glucantime and Peganum harmala extracts (aqueous and ethanol) in animal model was studied in BALB/c mice. These mice were divided in four groups according to receiving either one of these three agents or no treatment (control). The therapeutic response was evaluated according to parasitic load before and after treatment and also with measuring the size of the lesions. Results: The results showed that ethanol extract of Peganum harmala had good therapeutic efficacy in treatment of lesions in mice (P < 0.05) that this efficacy was significant in eighth week after the treatment. There was also a statistically significant difference between the groups regarding the parasitic load (P < 0.05). Conclusion: According to the results, it may be concluded that ethanol extract of Peganum harmala would have a good efficacy in treatment of cutaneous leishmaniasis that is comparable with glucantime. Results: As a result of our experiments was created new complex model of neutropenia and anemia with use of vincristine sulfate in dose of 1/10 LD50, which was inferior to none of previously used models in respect of pathologic changes rates and their statistic significance. Its positive advantages were lower quantity of preparation and possibility to regulate required levels of pathology manifestation. With our combined model of anemia and neutropenia both Epobiocrin and Neupogen demonstrated ability to stimulate erythropoiesis (increase of erythrocytes number, hemoglobin level, spleen mass coefficient) and leukopoiesis (increase of neutrophils level) in comparison with group I. Conclusion: Thus use of our model allowed to demonstrate that preparations are regulators both erythropoiesis and leukopoiesis which must be taken into account in medicine at immunocorrection treatment. Background: Insulin-like growth factor-I receptor (IGF-IR) which highly expression in the embryonic period in vivo and Maintain a low concentration levels in adulthood. As an important mediated factor IGF-IR take part in the regulation of cell growth, differentiation and proliferation. It also mediates mitogen signal, anti-apoptotic, induce vascular endothelial growth factor (VEGF) and necessity for cell type transformation. We investigated the expression and its clinical pathological alteration of IGF-IR in different parts of human hepatocellular carcinoma (HCC) and its paracancerous tissues. Methods: Using the immunohistochemistry and nested-PCR assay, IGF-IR and IGF-1R gene expression was detected in 30 HCC and their non-cancerous tissues. The relationship between IGF-IR and IGF-II or their clinical pathological characteristics was investigated. Results: The stronger expression of IGF-IR was found in either HCC or non-cancerous tissues. The positive rate of IGF-IR expression was 80.0% in HCC tissues, and 43.3% in non-cancerous tissues, respectively. A significant difference was present between them (c 2 = 8.53, P < 0.01). The positive expression of IGF-IR in HCC was correlated to tumor differentiation, but not to tumor number, size, HBsAg and AFP. The expressions of IGF-IR and IGF-II in HCC were of positive correlation. The level of IGF-IR expression was positively correlated with the corresponding degree of differentiation for which the incidence was 44.4% in the high differentiation group, 92.9% in the moderate differentiation, and 100% in the low differentiation group (Fisher's exact test). The IGF-IR and IGF-II expressed of moderate and low differentiation of HCC are more than high differentiation ones significantly, and they also had positive correlation in different degree of differentiation (P < 0.05). Conclusion: The overexpression of hepatic IGF-IR was associated with the occurrence and development of HCC. Background: It has been demonstrated that TGF-b1 played a key role in HSCs activation through interaction with bcatenin. This study was designed to elucidate the molecular mechanism involved in the effect of inhibition of b-catenin on TGF-b1 induced HSCs activation. Methods: HSC-T6 cells were transfected with pEGFP-C1-Dickkopf-1 (DKK-1, experiment group) and pEGFP-C1-neo (control group), while the normal group received PBS instead of DKK-1. All cells without the normal group were incubated with 1 ng/ml TGF-b1 for 2 hours. At the end of the experiment, the mRNA and protein levels of smad3, b-catenin and a-SMA in cells were analyzed via RT-PCR and western-blot. Results: Both mRNA and protein levels of b-catenin and a-SMA in HSCs were significantly increased by TGF-b1 in control group compared with normal group, whereas DKK-1 markedly reduced all the above parameters (p < 0.05, respectively). Moreover, DKK-1 significantly decreased the cell viability of HSC-T6 cells compared with control group. 
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